Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adamis Pharmaceuticals Co...

    NASDAQ: ADMP · Real-Time Price · USD
    0.78
    0.01 (1.50%)
    At close: Sep 07, 2023, 7:59 PM

    Adamis Pharmaceuticals Statistics

    Share Statistics

    Adamis Pharmaceuticals has 9.36M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 9.36M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 2,802

    FTD / Avg. Volume

    n/a
    		 0.09%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.97 and the forward PE ratio is null. Adamis Pharmaceuticals's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -0.97

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 5.33

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -31.39

    P/FCF Ratio

    n/a
    		 -0.95

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Adamis Pharmaceuticals has an Enterprise Value (EV) of 24.63M.

    EV / Sales

    n/a
    		 5.18

    EV / EBITDA

    n/a
    		 -1.01

    EV / EBIT

    n/a
    		 -0.95

    EV / FCF

    n/a
    		 -0.93

    Financial Position

    The company has a current ratio of 0.81, with a Debt / Equity ratio of -0.42.

    Current Ratio

    n/a
    		 0.81

    Quick Ratio

    n/a
    		 0.7

    Debt / Equity

    n/a
    		 -0.42

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -567.9

    Financial Efficiency

    Return on Equity is 3242.23% and Return on Invested Capital is 5383.58%.

    Return on Equity

    n/a
    		 3242.23%

    Return on Assets

    n/a
    		 -239.68%

    Return on Invested Capital

    n/a
    		 5383.58%

    Revenue Per Employee

    n/a
    		 $432,370.73

    Profits Per Employee

    n/a
    		 $-2,381,764.18

    Employee Count

    n/a
    		 11

    Asset Turnover

    n/a
    		 0.44

    Inventory Turnover

    n/a
    		 4.99

    Taxes

    Income Tax

    n/a
    		 2K

    Effective Tax Rate

    n/a
    		 -0.01%

    Stock Price Statistics

    The stock price has increased by 24.98% in the last 52 weeks. The beta is 1.28, so Adamis Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.28

    52-Week Price Change

    n/a
    		 24.98%

    50-Day Moving Average

    n/a
    		 1

    200-Day Moving Average

    n/a
    		 6.45

    Relative Strength Index (RSI)

    n/a
    		 43.5

    Average Volume (20 Days)

    n/a
    		 3,113,594

    Income Statement

    In the last 12 months, Adamis Pharmaceuticals had revenue of 4.76M and earned -26.2M in profits. Earnings per share was -12.24.

    Revenue

    n/a
    		 4.76M

    Gross Profit

    n/a
    		 -1.43M

    Operating Income

    n/a
    		 -25.06M

    Net Income

    n/a
    		 -26.2M

    EBITDA

    n/a
    		 -24.27M

    EBIT

    n/a
    		 -1.16B

    Earnings Per Share (EPS)

    n/a
    		 -12.24
    Full Income Statement

    Balance Sheet

    The company has 1.08M in cash and 342.56K in debt, giving a net cash position of 738.8K.

    Cash & Cash Equivalents

    n/a
    		 1.08M

    Total Debt

    n/a
    		 342.56K

    Net Cash

    n/a
    		 738.8K

    Retained Earnings

    n/a
    		 -304.56M

    Total Assets

    n/a
    		 8.96B

    Working Capital

    n/a
    		 -5.59B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -25.9M and capital expenditures -680.42K, giving a free cash flow of -26.58M.

    Operating Cash Flow

    n/a
    		 -25.9M

    Capital Expenditures

    n/a
    		 -680.42K

    Free Cash Flow

    n/a
    		 -26.58M

    FCF Per Share

    n/a
    		 -12.42
    Full Cash Flow Statement

    Margins

    Gross margin is -30.1%, with operating and profit margins of -526.88% and -550.86%.

    Gross Margin

    n/a
    		 -30.1%

    Operating Margin

    n/a
    		 -526.88%

    Pretax Margin

    n/a
    		 -550.82%

    Profit Margin

    n/a
    		 -550.86%

    EBITDA Margin

    n/a
    		 -510.24%

    EBIT Margin

    n/a
    		 -526.88%

    FCF Margin

    n/a
    		 -558.88%

    Dividends & Yields

    ADMP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -103.28%

    FCF Yield

    n/a
    		 -104.78%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ADMP.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 22, 2023. It was a backward split with a ratio of 1:70.

    Last Split Date

    n/a
    		 May 22, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:70

    Scores

    Altman Z-Score

    n/a
    		 -51.31

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist